In situations where there is an insufficient amount of immunogenic tumor retrieved, DCs can also be exposed to more generalized antigens, such as CEA, although this has not been shown to induce a significant survival benefit in most patients [94,95,96]. The gene discussed is CEACAM5; the disease is neoplasm.